Boehringer Ingelheim and Enara Bio Enter Strategic Collaboration and Licensing Agreement to Discover Novel Shared Antigens for Cancer Immunotherapies INGELHEIM, Germany & OXFORD, England & LONDON–(BUSINESS WIRE)–Boehringer Ingelheim and Enara Bio, today announced that they have entered into a strategic collaboration and licensing a…